Product Information and Reviews

FDA Grants Priority Review Of Gamunex(R) As A Treatment For Neurological Disorder CIDP (Medical News Today)

12 May 2008

Talecris Biotherapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has granted a Priority Review of Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

Up Next, Recaps & Links (CBS News)

12 May 2008

Stories, links and the place to get more information on stories on CBS News Sunday Morning .

Powerset unveils 'Google-killer' (Macworld UK)

12 May 2008

The public will get its first chance Monday to test a search engine from start-up Powerset that eschews conventional keyword technology and instead is designed to understand the meaning of Web pages.